Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial

Authors:
  • EPEva-Maria Pöllabauer
    Eva-Maria Pöllabauer
  • GAGerald Aichinger
    Gerald Aichinger
  • DPDaniel Portsmouth
    Daniel Portsmouth
  • ALAlexandra Löw-Baselli
    Alexandra Löw-Baselli
  • SFSandor Fritsch
    Sandor Fritsch
  • ILIan Livey
    Ian Livey
  • BCBrian A Crowe
    Brian A Crowe
  • MSMichael Schwendinger
    Michael Schwendinger
  • PBPeter Brühl
    Peter Brühl
  • APAndreas Pilz
    Andreas Pilz
  • TDThomas Dvorak
    Thomas Dvorak

Abstract
No abstract available

This publication has 37 references indexed in Scilit: